🇺🇸 FDA
Patent

US 10548946

Therapeutic compositions for neutralizing type I interferons, and methods of use

granted A61KA61K38/162A61P

Quick answer

US patent 10548946 (Therapeutic compositions for neutralizing type I interferons, and methods of use) held by The Government of the United States, as represented by the Secretary of the Army expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States, as represented by the Secretary of the Army
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/162, A61P, A61P31/12, A61P37/06